Pfizer On Sidelines As AstraZeneca Offer Window Opens
Pfizer Inc. has stayed quiet since Wednesday after restrictions imposed by U.K. takeover regulators loosened, allowing it to make another run at British rival AstraZeneca PLC after a previous $118 billion...To view the full article, register now.
Already a subscriber? Click here to view full article